Literature DB >> 7943237

Cholecystokinin rapidly activates mitogen-activated protein kinase in rat pancreatic acini.

R D Duan1, J A Williams.   

Abstract

The existence and activation of mitogen-activated protein (MAP) kinase in isolated pancreatic acini have been demonstrated. Immunoblotting and immunoprecipitation revealed two forms of MAP kinase in pancreatic acini, with relative molecular masses of approximately 42 and 44 kDa. Both forms of MAP kinase were activated by cholecystokinin (CCK). The threshold concentration of CCK was approximately 3 pM, and the maximal effect occurred at 1 nM, which enhanced MAP kinase activity by 2.5-fold, as determined in polyacrylamide gel copolymerized with substrate myelin basic protein. Activation of MAP kinase by CCK was rapid, reaching a maximum within 5-10 min that subsequently declined. Bombesin and carbachol but not secretin or vasoactive intestinal peptide also activated MAP kinase. CCK-induced activation of MAP kinase may be mediated by protein kinase C, since 12-O-tetradecanoylphorbol 13-acetate (TPA) mimicked the effect of CCK and staurosporine concentration dependently inhibited the action of CCK. Treatment of acini with thapsigargin, ionomycin, or ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid did not influence MAP kinase, indicating that mobilization of intracellular calcium by CCK is not important in activation of acinar MAP kinase. CCK and TPA increased tyrosine phosphorylation of both 42- and 44-kDa forms. Genistein and tyrphostin 23, the inhibitors of tyrosine kinase, suppressed the activation of MAP kinase by CCK. In conclusion, MAP kinase in pancreatic acini is activated by agonists related to hydrolysis of phosphoinositide, via a mechanism involving protein kinase C and tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943237     DOI: 10.1152/ajpgi.1994.267.3.G401

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  23 in total

1.  Nicotine-induced proliferation of isolated rat pancreatic acinar cells: effect on cell signalling and function.

Authors:  P Chowdhury; C Bose; K B Udupa
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

Review 2.  Exploring the role of homeobox and zinc finger proteins in pancreatic cell proliferation, differentiation, and apoptosis.

Authors:  R Urrutia
Journal:  Int J Pancreatol       Date:  1997-08

Review 3.  Cholecystokinin receptors.

Authors:  P Boden; M D Hall; J Hughes
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

4.  Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5.

Authors:  P Cordelier; J P Estève; C Bousquet; N Delesque; A M O'Carroll; A V Schally; N Vaysse; C Susini; L Buscail
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

5.  CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice.

Authors:  Yaqing Zhang; Wei Yan; Esha Mathew; Filip Bednar; Shanshan Wan; Meredith A Collins; Rebecca A Evans; Theodore H Welling; Robert H Vonderheide; Marina Pasca di Magliano
Journal:  Cancer Immunol Res       Date:  2014-02-11       Impact factor: 11.151

6.  Cholecystokinin activation of 70-kDa S6 kinase in exocrine pancreas.

Authors:  K Inushima; Y Okabayashi; K Sakaguchi; Y Matsumura; S Kimura; Y Inoue; M Kasuga
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

7.  Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity.

Authors:  Jun Wu; Ake Nilsson; Bo A G Jönsson; Hanna Stenstad; William Agace; Yajun Cheng; Rui-Dong Duan
Journal:  Biochem J       Date:  2006-02-15       Impact factor: 3.857

8.  Mechanisms for nicotine in the development and progression of gastrointestinal cancers.

Authors:  Kendal Jensen; Syeda Afroze; Md Kamruzzaman Munshi; Micheleine Guerrier; Shannon S Glaser
Journal:  Transl Gastrointest Cancer       Date:  2012-04

9.  Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.

Authors:  Yaqing Zhang; Wei Yan; Meredith A Collins; Filip Bednar; Sabita Rakshit; Bruce R Zetter; Ben Z Stanger; Ivy Chung; Andrew D Rhim; Marina Pasca di Magliano
Journal:  Cancer Res       Date:  2013-10-04       Impact factor: 12.701

Review 10.  Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor.

Authors:  Erin E Cawston; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.